Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus

Tuncel, ÖZLEM; AKYOL, DENİZ; PULLUKÇU, HÜSNÜ; YAMAZHAN, TANSU; Tasbakan, MELTEM; Sertoz, Ozen

doi:10.4274/vhd.galenos.2019.0006

Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus

Tuncel O. K. , AKYOL D. , PULLUKÇU H. , YAMAZHAN T. , Tasbakan M. , Sertoz O. O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.25, no.1, pp.25-31, 2019 (Journal Indexed in ESCI)

Publication Type: Article / Article
Volume: 25 Issue: 1
Publication Date: 2019
Doi Number: 10.4274/vhd.galenos.2019.0006
Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Page Numbers: pp.25-31

Abstract

Objectives: Data about the psychosocial side effects of direct-acting antiviral agents (DAA) used for the treatment of hepatitis C virus (HCV) infection is scarce. In this study, it is aimed to assess the psychiatric and sexual effects of ledipasvir/sofosbuvir (L/S) combination and paritaprevir-ritonavir-ombitasvir-dasabuvir (PROD) combination in patients with HCV infection.